[HTML][HTML] Merkel cell carcinoma: epidemiology, target, and therapy

…, LA Cornelius, LF Hutchins, JC Becker, L Gao - Current dermatology …, 2014 - Springer
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumor of the skin with a rising
incidence. MCC has metastatic potential regardless the size of the primary tumor and a 5-…

[HTML][HTML] Underrepresentation of patients 65 years of age or older in cancer-treatment trials

LF Hutchins, JM Unger, JJ Crowley… - … England Journal of …, 1999 - Mass Medical Soc
Background Studies have documented the underrepresentation of women and blacks in
clinical trials, and their recruitment is now federally mandated. However, little is known about …

The bases for temperature zonation in geographical distribution

LW Hutchins - Ecological monographs, 1947 - JSTOR
Zonation, as the term is employed here, refers to the limited north-south distributions which
character-ize most species. It is well known that these restricted distributions are to be …

Relevance of pathological complete response after neoadjuvant therapy for breast cancer

…, I Makhoul, L Hutchins - Breast cancer: basic …, 2016 - journals.sagepub.com
Breast cancer is a heterogeneous disease, and the different biological subtypes have
different prognostic impacts. Neoadjuvant trials have recently become popular as they offer …

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

…, GT Budd, L Hutchins, E Lower, L Laufman… - Journal of Clinical …, 2005 - ascopubs.org
Purpose This randomized, controlled, multicenter, open-label, phase III study compared
docetaxel versus paclitaxel in patients with advanced breast cancer that had progressed after an …

The BioMart community portal: an innovative alternative to large, centralized data repositories

…, C Hoede, S Hu, ZL Hu, L Hutchins… - Nucleic acids …, 2015 - academic.oup.com
The BioMart Community Portal ( www.biomart.org ) is a community-driven effort to provide a
unified interface to biomedical databases that are distributed worldwide. The portal provides …

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and …

…, DE Schuller, JF Ensley, LF Hutchins… - Journal of Clinical …, 1992 - ascopubs.org
PURPOSE The Southwest Oncology Group (SWOG) conducted a randomized comparison
of cisplatin plus fluorouracil (5-FU) and carboplatin plus 5-FU versus single-agent …

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

…, S Smith, D Joske, I Lewis, L Hutchins… - Blood, The Journal …, 2011 - ashpublications.org
Romidepsin (depsipeptide or FK228) is a histone deacetylase inhibitor, one of a new class
of agents active in T-cell lymphoma. A phase 2 trial was conducted in cutaneous (CTCL) and …

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And …

…, VG Vogel, JF Kroener, LF Hutchins… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Patients with early-stage, hormone receptor–positive breast cancer have considerable
residual risk for recurrence after completing 5 years of adjuvant tamoxifen. In May 2001, …

[BOOK][B] Bi any other name: Bisexual people speak out

L Ka'ahumanu, L Hutchins - 2015 - books.google.com
… Bi Any Other Name© 2015 edited by Lani Ka’ahumanu and Loraine Hutchins All Rights …
21By Loraine Hutchins, writing an impromptu personal response to the above blog quote. …